CAMLINFINE Stock Overview
Engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Camlin Fine Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹130.39 |
| 52 Week High | ₹139.70 |
| 52 Week Low | ₹79.95 |
| Beta | 0.90 |
| 1 Month Change | 12.07% |
| 3 Month Change | 24.47% |
| 1 Year Change | -2.59% |
| 3 Year Change | 11.54% |
| 5 Year Change | 51.18% |
| Change since IPO | 51.09% |
Recent News & Updates
A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb
Nov 27
Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19Recent updates
A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb
Nov 27Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump
Mar 29Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?
Sep 02Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Apr 06Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic
Feb 19Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 17Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?
Oct 15Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jan 15Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture
Jan 04Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching
Nov 30Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Oct 05At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Aug 20Estimating The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jun 30Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26What Is Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Share Price Doing?
Feb 15Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Popular Amongst Insiders?
Feb 05
Camlin Fine Sciences (NSE:CAMLINFINE) Shareholders Booked A 29% Gain In The Last Year
Jan 26Here's What To Make Of Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Jan 16Don't Ignore The Fact That This Insider Just Sold Some Shares In Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jan 06Should You Be Adding Camlin Fine Sciences (NSE:CAMLINFINE) To Your Watchlist Today?
Jan 04Can Mixed Fundamentals Have A Negative Impact on Camlin Fine Sciences Limited (NSE:CAMLINFINE) Current Share Price Momentum?
Dec 24How Should Investors React To Camlin Fine Sciences' (NSE:CAMLINFINE) CEO Pay?
Dec 13Does Camlin Fine Sciences's (NSE:CAMLINFINE) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 02Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Nov 21Is Now An Opportune Moment To Examine Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Nov 09The Camlin Fine Sciences (NSE:CAMLINFINE) Share Price Is Up 49% And Shareholders Are Holding On
Oct 27What Do The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Tell Us?
Oct 14Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 29% Price Boost Is Out Of Tune With Earnings
Oct 01Here's Why I Think Camlin Fine Sciences (NSE:CAMLINFINE) Might Deserve Your Attention Today
Sep 30What Kind Of Shareholders Hold The Majority In Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Shares?
Sep 17Read This Before Judging Camlin Fine Sciences Limited's (NSE:CAMLINFINE) ROE
Sep 04Shareholder Returns
| CAMLINFINE | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 5.5% | -2.4% | -2.5% |
| 1Y | -2.6% | 3.5% | 17.9% |
Return vs Industry: CAMLINFINE underperformed the Indian Chemicals industry which returned 3.8% over the past year.
Return vs Market: CAMLINFINE underperformed the Indian Market which returned 18.7% over the past year.
Price Volatility
| CAMLINFINE volatility | |
|---|---|
| CAMLINFINE Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: CAMLINFINE has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: CAMLINFINE's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1931 | 624 | n/a | www.camlinfs.com |
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, and rosemary extract that are used to enhance the shelf life under the Xtendra and NaSure brands. It also provides aroma ingredients, including vanillin and ethyl vanillin; health and wellness products; and performance chemicals, such as hydroquinone and catechol.
Camlin Fine Sciences Limited Fundamentals Summary
| CAMLINFINE fundamental statistics | |
|---|---|
| Market cap | ₹21.78b |
| Earnings (TTM) | -₹2.23b |
| Revenue (TTM) | ₹16.06b |
1.4x
P/S Ratio-9.8x
P/E RatioIs CAMLINFINE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CAMLINFINE income statement (TTM) | |
|---|---|
| Revenue | ₹16.06b |
| Cost of Revenue | ₹9.50b |
| Gross Profit | ₹6.57b |
| Other Expenses | ₹8.80b |
| Earnings | -₹2.23b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -13.32 |
| Gross Margin | 40.89% |
| Net Profit Margin | -13.89% |
| Debt/Equity Ratio | 111.2% |
How did CAMLINFINE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 05:25 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Camlin Fine Sciences Limited is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ankur Periwal | Axis Capital Limited |
| Satish Kumar | CGS International |
| null null | DBS Bank Ltd |